3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
60
Phase NA
30
Phase 1
30
Phase 3
15
Phase 1/2
15
Phase EARLY_PHASE1
5
Phase 2/3
5
Phase 4
2
Status
Recruiting
1
Completed
1
Sponsor Class
OTHER
1
INDUSTRY
1
Study Type
Interventional
2
Sponsor
Cancer Type
Breast
28
Gastrointestinal
21
Genitourinary
15
Other hematologic neoplasm
13
Thoracic
12
Lymphoid
9
Gynecologic
9
Dermatologic
9
Plasma cell
8
Head & Neck
7
CNS
7
Sarcoma
5
Myeloid
5
Classical hematology
5
Tumor-Agnostic
2
Other
2
Endocrine
2
Other solid neoplasm
1
Conditions
Pituitary Diseases
1
Pain, Postoperative
1
Multiple Endocrine Neoplasia Type 1
1
Interventions
Fulvestrant
1
Alpelisib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Phase 4
×
Endocrine
×
90 days
×
Clear all
NCT05631795
2026-04-07
ALPINIST
Novartis
Phase 4
Completed
40 enrolled
NCT06353529
2026-03-12
POPPY
Hamilton Health Sciences Corporation
Phase 4
Recruiting
108 enrolled